Naoji Umemoto is an author at Teijin (Japan) specializing in medicine, immunology, and antibody engineering.
Top concepts
MedicineImmunologyAntibody EngineeringImmunotherapyPharmacologyCancer ResearchOncologyTumor MicroenvironmentAllergyBiochemistry
Publications per year
1982–2001
14
14
Monoclonal anti-MM46 antibody:ricin A chain conjugate: in vitro and in vivo antitumor activity.
Masao Seto, Naoji Umemoto, Masahiko Saito et al. · PubMed · 1982 · 50 citations
Rows per page
1–5 of 14